interferoninduc
antivir
ubiquitinlik
protein
ubl
major
enzym
mediat
isgyl
protein
interferonstimul
cell
address
broad
substrat
select
found
rang
substrat
extend
even
includ
mani
exogen
express
foreign
protein
conjug
restrict
newli
synthes
pool
protein
physic
associ
polyribosom
result
lead
model
isgyl
broadli
modifi
newli
synthes
protein
cotransl
manner
suggest
context
interferonstimul
cell
newli
translat
viral
protein
may
primari
target
consist
demonstr
isgyl
human
papillomaviru
hpv
capsid
protein
dominantinhibitori
effect
infect
pseudovirus
kd
ubiquitinlik
protein
ubl
rapidli
induc
type
interferon
ifna
b
induct
interferon
impli
year
ago
compon
innat
immun
respons
farrel
et
al
howev
recent
confirm
antivir
activ
sever
type
virus
includ
influenza
sindbi
herp
human
immunodefici
ebola
hsiang
et
al
lenschow
et
al
okumura
et
al
okumura
et
al
addit
sever
virus
evolv
mechan
interf
function
protein
influenza
b
block
conjug
chang
et
al
yuan
krug
sar
coronaviru
encod
deconjug
enzym
lindner
et
al
vaccinia
protein
bind
block
antivir
activ
guerra
et
al
abil
conjug
protein
shown
case
essenti
antivir
activ
giannakopoulo
et
al
lai
et
al
biochem
function
conjug
basi
antivir
activ
conjug
remain
unknown
wherea
rapidli
induc
ifnstimul
protein
farrel
et
al
conjug
becom
appar
hr
ifn
stimul
loeb
haa
correspond
delay
induct
enzym
dastur
et
al
human
enzym
yuan
krug
enzym
durfe
et
al
kim
et
al
zhao
et
al
major
human
hect
domain
ligas
contain
ntermin
repeat
dastur
et
al
wong
et
al
deplet
result
dramat
decreas
conjug
affect
conjug
vast
major
cellular
target
protein
dastur
et
al
coexpress
nonifnstimul
cell
reconstitut
broad
robust
conjug
dastur
et
al
takeuchi
et
al
wong
et
al
also
shown
antivir
activ
influenza
viru
zhao
et
al
efp
ring
report
addit
howev
singl
target
report
zou
zhang
therefor
wherea
addit
protein
may
play
role
conjug
repres
core
ifninduc
compon
conjug
system
human
cell
proteom
studi
identifi
cellular
protein
target
isgyl
malakhov
et
al
takeuchi
et
al
wong
et
al
zhao
et
al
target
present
mani
cellular
compart
function
class
protein
particularli
overrepres
although
ifninduc
human
protein
identifi
zhao
et
al
common
structur
primari
sequenc
element
confer
conjug
identifi
chain
observ
importantli
small
fraction
pool
given
target
protein
gener
modifi
zhao
et
al
observ
rais
follow
question
singl
ligas
respons
target
larg
divers
set
protein
biochem
effect
conjug
target
protein
modif
small
fraction
individu
target
protein
signific
effect
overal
activ
protein
find
present
lead
model
account
broad
substrat
target
system
provid
basi
understand
antivir
activ
conjug
system
target
broad
rang
protein
conjug
observ
experiment
treat
hela
cell
ifnb
prepar
total
cell
lysat
hr
posttreat
immunoblot
antibodi
figur
surprisingli
lysat
immunoblot
antibodi
previous
identifi
target
protein
difficult
observ
modif
seen
figur
two
protein
wherea
modif
protein
could
detect
long
exposur
modif
figur
four
constitut
express
target
protein
could
detect
tabl
avail
onlin
success
rate
valid
ifninduc
target
protein
higher
three
five
target
confirm
shown
figur
summar
tabl
neg
control
five
protein
previous
identifi
target
modif
examin
none
detect
modifi
ifnbstimul
cell
tabl
conjug
also
gener
express
core
compon
conjug
system
fourplasmid
transfect
nonifnstimul
cell
seen
figur
top
robust
conjug
observ
cell
subject
fourplasmid
transfect
howev
difficult
detect
isgyl
individu
endogen
express
target
protein
shown
moesin
figur
although
ifnstimul
hela
cell
low
level
modif
could
detect
long
exposur
data
shown
modif
two
seven
previous
identifi
target
could
valid
method
tabl
investig
problem
target
protein
valid
nonifnstimul
cell
transfect
plasmid
express
individu
epitopetag
target
protein
along
plasmid
encod
four
core
conjug
compon
fiveplasmid
transfect
surprisingli
scenario
modif
detect
previous
identifi
target
protein
test
nine
nine
protein
shown
figur
summar
tabl
result
prompt
us
assay
presumpt
neg
control
sever
epitopetag
human
protein
previous
identifi
target
five
seven
also
found
isgyl
includ
dlg
figur
tabl
sever
nonhuman
protein
also
assay
includ
e
coli
bgalactosidas
shigella
flexneri
ospg
salmonella
typhimurium
sopa
tap
epitop
tag
two
copi
protein
sequenc
calmodulinbind
protein
two
viral
protein
hiv
integras
modifi
express
along
conjug
compon
figur
tabl
three
protein
identifi
consist
isgyl
assay
system
gfp
human
kd
carboxytermin
fragment
paxillin
also
confirm
natur
epitop
tag
influenc
modif
see
figur
modif
tap
ha
tabl
other
attempt
map
domain
target
protein
recogn
isgyl
enzym
three
nonoverlap
fragment
assay
modif
figur
surprisingli
three
fragment
protein
isgyl
similar
result
seen
two
nonoverlap
fragment
mxa
figur
indic
isgyl
machineri
recogn
singl
epitop
even
within
individu
protein
togeth
result
suggest
least
fiveplasmid
transfect
assay
isgyl
machineri
recogn
target
protein
broad
rel
nonspecif
manner
address
whether
broad
target
recognit
fiveplasmid
transfect
assay
relat
overexpress
transfect
target
protein
monitor
sever
time
point
transfect
protein
level
modif
two
exogen
express
target
protein
rel
correspond
endogen
express
protein
figur
left
panel
show
rel
level
exogen
endogen
express
protein
absenc
express
target
protein
without
use
antibodi
detect
protein
exogen
express
protein
could
detect
hr
posttransfect
level
exogen
protein
exceed
endogen
even
hr
posttransfect
wherea
level
exogen
protein
similar
perhap
slightli
higher
endogen
hr
posttransfect
correct
transfect
effici
howev
hr
time
point
exogen
express
protein
clearli
less
abund
endogen
express
protein
isgyl
exogen
express
protein
detect
target
protein
express
four
conjug
compon
figur
middl
contrast
modif
endogen
protein
detect
time
point
figur
right
therefor
preferenti
modif
exogen
express
protein
due
higher
steadyst
level
exogen
express
target
protein
account
preferenti
modif
exogen
express
target
protein
consid
fiveplasmid
transfect
assay
entir
pool
target
protein
synthes
window
time
conjug
machineri
activ
contrast
assay
endogen
express
protein
examin
fraction
target
protein
synthes
conjug
machineri
activ
function
rate
synthesi
protein
also
fiveplasmid
transfect
mrna
level
encod
exogen
express
protein
higher
correspond
endogen
express
mrna
base
three
exampl
figur
suggest
exogen
express
protein
though
present
higher
steadyst
level
translat
higher
rate
distinct
suggest
conjug
might
limit
newli
synthes
pool
given
target
protein
addit
observ
consist
rel
high
success
rate
valid
ifninduc
target
eg
mxa
ifnstimul
cell
see
tabl
wherein
entir
pool
protein
definit
newli
synthes
test
hypothesi
isgyl
limit
newli
synthes
protein
three
way
one
approach
figur
intracellular
pool
target
protein
first
establish
plasmid
transfect
twentyfour
hour
later
conjug
machineri
express
fourplasmid
transfect
without
cotransfect
sirna
target
mrna
encod
plasmidexpress
target
protein
extract
prepar
hr
second
transfect
target
protein
analyz
isgyl
hypothesi
predict
modif
depend
protein
synthesi
sirnamedi
destruct
mrna
would
result
loss
isgyl
target
protein
preexist
pool
target
protein
synthes
first
hr
would
modifi
contrast
absenc
specif
sirna
presenc
offtarget
sirna
target
protein
would
continu
synthes
isgyl
would
observ
experi
depend
rate
degrad
target
protein
target
analyz
protein
level
declin
sirna
transfect
figur
rtpcr
also
confirm
specif
sirna
led
knockdown
target
sirna
hr
posttransfect
data
shown
figur
b
isgyl
exogen
express
target
protein
cell
transfect
plasmid
express
epitopetag
target
protein
top
two
panel
either
alon
lane
combin
lane
combin
lane
cell
extract
prepar
hr
posttransfect
analyz
immunoblot
use
indic
antibodi
show
result
analysi
isgyl
protein
observ
absenc
sirna
presenc
offtarget
sirna
greatli
diminish
presenc
specif
sirna
result
consist
hypothesi
protein
must
activ
synthes
order
modifi
pulselabel
scheme
use
global
determin
whether
isgyl
limit
protein
synthes
window
time
conjug
machineri
activ
preliminari
experi
determin
conjug
becam
evid
hr
fourplasmid
transfect
therefor
cell
transfect
four
plasmid
puls
label
slabel
cystein
either
conjug
occur
hr
posttransfect
conjug
occur
hr
posttransfect
total
cell
lysat
collect
hr
posttransfect
antiflag
immunoprecipit
analyz
sdspage
autoradiographi
hypothesi
predict
scontain
protein
label
earli
time
point
would
isgyl
wherea
protein
label
late
time
point
conjug
occur
would
suscept
isgyl
broad
rang
label
protein
conjug
cell
label
hr
time
point
wherea
pattern
label
immunoprecipit
protein
earli
label
period
slightli
seen
control
untransfect
cell
figur
compar
lane
lane
slight
signal
background
lane
correspond
earli
label
period
may
due
either
secondari
mode
conjug
eg
minor
conjug
pathway
due
turnov
scystein
reincorpor
newli
translat
protein
later
time
point
experi
also
perform
use
express
plasmid
encod
mutant
lack
ntermin
ubiquitinlik
domain
conjug
similarli
wildtyp
slabel
protein
coimmunoprecipit
cell
label
hr
time
point
cell
label
hr
time
point
figur
lane
antiflag
western
blot
total
extract
indic
conjug
robust
sampl
express
conjug
compon
regardless
point
cell
label
scystein
figur
tca
precipit
extract
indic
total
protein
label
dpmmg
total
protein
similar
among
sampl
data
shown
result
consist
notion
protein
subject
conjug
synthes
window
time
conjug
machineri
activ
third
assay
util
puromycin
inhibit
translat
coval
incorpor
carboxytermin
end
nascent
polypeptid
chain
hypothesi
predict
puromycin
treatment
cell
activ
conjug
would
lead
gener
polypeptid
contain
puromycin
cell
therefor
subject
fourplasmid
transfect
threeplasmid
transfect
omit
individu
enzym
compon
twentyfour
hour
later
cell
treat
puromycin
min
prepar
cell
extract
conjug
immunoprecipit
antiflag
antibodi
analyz
immunoblot
antipuromycin
antibodi
shown
figur
cell
express
four
conjug
compon
contain
broad
rang
polypeptid
modifi
puromycin
cell
extract
prepar
indic
time
point
transfect
analyz
immunoblot
antibodi
compar
exogen
endogen
protein
level
left
middl
cell
transfect
plasmid
express
plu
cell
extract
collect
indic
time
point
analyz
antibodi
tap
detect
isgyl
exogen
target
asterisk
mark
earliest
detect
conjug
right
cell
transfect
plasmid
express
exogen
target
protein
extract
analyz
modif
endogen
express
b
schemat
experiment
design
block
synthesi
exogen
target
protein
block
isgyl
plasmid
express
epitopetag
target
protein
transfect
time
zero
target
mrna
solid
line
target
protein
dash
line
accumul
next
hr
plasmid
express
transfect
either
without
sirna
recogn
target
protein
mrna
absenc
target
sirna
left
modif
target
protein
expect
occur
conjug
compon
doubl
line
accumul
target
protein
continu
synthes
presenc
target
sirna
right
target
protein
mrna
would
destroy
conjug
compon
express
previous
synthes
protein
persist
function
rate
destruct
continu
target
protein
synthesi
requir
isgyl
isgyl
target
protein
occur
c
knockdown
target
protein
mrna
block
target
protein
modif
cell
transfect
plasmid
express
either
transfect
hr
later
without
sirna
offtarget
sirna
htfr
human
transferrin
receptor
cell
extract
prepar
hr
second
transfect
analyz
immunoblot
antitap
antibodi
polypeptid
detect
cell
treat
puromycin
cell
lack
small
amount
conjug
correspond
low
basal
express
enzym
nonifntr
cell
data
shown
result
therefor
consist
model
newli
synthes
protein
target
isgyl
isgyl
newli
synthes
protein
suggest
modif
might
occur
cotransl
therefor
determin
whether
endogen
express
cofraction
ribosom
andor
polysom
hela
cell
treat
ifnb
hr
cell
extract
fraction
sucros
gradient
sediment
ribosomeand
polysomecontain
fraction
includ
ribosom
subunit
identifi
characterist
absorb
profil
nm
confirm
immunoblot
antiribosom
subunit
antibodi
shown
figur
vast
major
protein
within
polysomecontain
fraction
cofraction
ribosom
extract
treat
rnase
figur
destroy
polysom
lead
larg
increas
number
ribosom
suggest
associ
polysom
via
ribosom
rather
mrna
consist
cofraction
ribosom
extract
treat
edta
figur
dissoci
polysom
ribosom
subunit
edta
also
releas
nascent
polypeptid
subunit
uller
et
al
valent
et
al
suggest
unlik
tether
ribosom
via
nascent
polypeptid
hect
domain
ligas
primari
sequenc
similar
hochrain
et
al
ifn
induc
function
conjug
neither
endogen
express
anoth
unrel
hect
cofraction
polysom
figur
contain
four
welldefin
rcc
repeat
residu
three
less
wellconserv
repeat
first
amino
acid
hadjebi
et
al
delet
entir
region
drcc
abrog
isgyl
target
protein
dastur
et
al
delet
amino
acid
howev
protein
retain
catalyt
activ
base
autoconjug
activ
figur
fulllength
hatag
express
transfect
present
polysom
fraction
figur
although
also
present
earlier
ribosomecontain
fraction
gradient
probabl
due
overexpress
rel
ifninduc
level
c
cell
treat
puromycin
contain
polypeptid
modifi
puromycin
cell
transfect
either
four
plasmid
three
plasmid
without
twentyfour
hour
posttransfect
cell
harvest
treat
mm
puromycin
min
cell
extract
prepar
immunoprecipit
antiflag
antibodi
immunoblot
antipuromycin
antibodi
hela
cell
contrast
hadrcc
protein
present
almost
exclus
earliest
fraction
gradient
therefor
repeat
region
essenti
isgyl
polysom
associ
find
present
implic
ident
biolog
relev
target
type
ifn
secret
virusinfect
cell
establish
antivir
state
uninfect
surround
cell
cell
like
next
site
viru
infect
propos
isgyl
system
design
target
newli
synthes
viral
protein
howev
even
among
newli
synthes
protein
isgyl
ineffici
rais
question
modif
small
fraction
viral
protein
could
signific
antivir
effect
answer
may
lie
fact
structur
protein
among
activ
synthes
viral
protein
must
often
assembl
precis
repeat
geometr
configur
form
infecti
viru
particl
eg
capsid
protein
therefor
isgyl
even
small
fraction
total
pool
viral
structur
protein
might
dominantneg
effect
product
infecti
viru
capsid
protein
isgyl
transfect
experi
figur
therefor
employ
hpv
pseudoviru
psv
system
measur
effect
isgyl
infect
buck
et
al
buck
thompson
papillomaviru
virion
compos
molecul
capsid
protein
molecul
buck
et
al
express
presenc
kbp
gfp
express
plasmid
plasmid
packag
viral
genom
dna
psv
isol
velocitydens
gradient
infect
measur
quantit
deliveri
gfp
report
plasmid
naiv
cell
pseudovirus
gener
cell
conjug
either
occur
cotransfect
enzym
occur
cotransfect
inact
mutant
form
enzym
presenc
assembl
psv
expect
gradient
fraction
buck
et
al
confirm
transmiss
electron
microscopi
data
shown
isgyl
psv
fraction
total
protein
isgyl
figur
total
amount
protein
isgyl
psv
fraction
less
control
psv
fraction
togeth
observ
indic
isgyl
incorpor
psv
particl
overal
yield
psv
decreas
examin
infect
isgyl
nonisgyl
psv
peak
gradient
fraction
ad
cultur
media
cell
follow
quantit
gfpposit
cell
fac
analysi
without
normal
total
concentr
infect
isgyl
psv
decreas
rel
nonisgyl
psv
three
independ
experi
figur
normal
infect
isgyl
psv
lower
nonisgyl
psv
figur
result
establish
lowlevel
isgyl
viral
structur
protein
dominantneg
effect
viru
infect
shown
rang
target
protein
extrem
broad
newli
synthes
protein
target
isgyl
associ
translat
machineri
find
suggest
system
design
target
newli
synthes
protein
limit
target
protein
select
find
impli
context
interferon
respons
viral
protein
rather
cellular
protein
may
princip
target
conjug
system
protein
extract
interferonstimul
hela
cell
cofraction
polysom
analys
suggest
associ
core
compon
ribosom
subunit
exit
tunnel
nascent
polypeptid
subunit
kramer
et
al
attract
model
modifi
newli
synthes
polypeptid
cotransl
emerg
exit
tunnel
interest
protein
modif
enzym
identifi
ribosom
associ
function
near
exit
tunnel
includ
methionin
isopeptidas
raue
et
al
vetro
chang
ntermin
acetyltransferas
green
et
al
pestana
pitot
chaperon
aid
cotransl
fold
protein
kramer
et
al
polysom
associ
suggest
inclus
translat
system
requir
reconstitut
vitro
isgyl
figur
form
either
absenc
psv
presenc
psv
conjug
system
gfpposit
cell
count
hr
postinfect
fac
infect
wildtyp
psv
set
result
present
without
middl
right
normal
total
protein
concentr
error
bar
indic
standard
error
mean
three
independ
experi
perform
triplic
turn
like
requir
direct
test
cotransl
model
also
import
note
though
rang
target
protein
appear
extrem
broad
newli
synthes
protein
isgyl
assay
factor
might
influenc
suscept
modif
includ
rate
translat
cotransl
fold
rate
sequenc
secondari
structur
context
lysin
acceptor
interferonstimul
cell
prime
defend
impend
viral
infect
suggest
newli
translat
viral
protein
might
biolog
relev
target
system
low
degre
target
protein
select
system
consist
requir
innat
immun
respons
protect
cell
wide
rang
pathogen
implic
model
modif
cellular
target
protein
may
simpli
collater
damag
attempt
target
viral
protein
turn
may
tie
observ
isgyl
rel
ineffici
ineffici
isgyl
system
might
protect
excess
damag
cellular
protein
time
still
effect
antivir
due
dominantneg
effect
abundantli
express
viru
structur
protein
shown
hpv
pseudoviru
system
result
consist
result
show
mutant
form
viral
structur
protein
dominantneg
effect
infect
addit
potenti
dominantneg
effect
isgyl
necessarili
limit
effect
viru
structur
protein
viral
protein
oligomer
would
potenti
biolog
relev
target
model
biochem
function
conjug
remain
unknown
two
gener
possibl
signal
anoth
protein
protein
complex
eg
way
ubiquitin
signal
proteasom
simpli
disrupt
function
protein
conjug
evid
support
latter
studi
examin
individu
target
protein
jeon
et
al
zou
et
al
may
also
infer
protein
sequenc
comparison
mammalian
speci
unlik
ubiquitin
ubl
protein
sequenc
diverg
residu
ident
human
mous
rat
dog
cow
sheep
protein
sequenc
suggest
diverg
mammalian
protein
unlik
retain
common
signal
function
similar
retain
reflect
requir
maintain
ubiquitinlik
fold
product
interact
conjug
enzym
therefor
suggest
function
gener
disrupt
target
protein
function
particular
function
viral
protein
hpv
pseudoviru
system
provid
proof
principl
lowlevel
isgyl
viru
structur
protein
dominantneg
effect
viru
infect
precis
step
infect
hpv
pseudovirus
affect
isgyl
hpv
capsid
yet
known
could
rang
receptor
recognit
defect
endocytosi
releas
endocyt
compart
deliveri
packag
dna
nucleu
effect
type
interferon
hpv
replic
known
complex
beglin
et
al
howev
multipl
studi
indic
hpv
interfer
express
andor
function
compon
interferon
respons
barnard
mcmillan
chang
laimin
nee
et
al
ronco
et
al
addit
topic
ifna
approv
treatment
certain
hpv
lesion
slade
et
al
result
present
warrant
examin
role
system
respons
hpv
lesion
type
ifn
broadli
effect
protein
mani
class
virus
antibodi
plasmid
sirna
antibodi
plasmid
use
studi
list
tabl
smartpool
sirna
suppli
dharmacon
addit
sirna
sequenc
htfr
aaggtgt
cell
cultur
ifnb
treatment
transfect
immunoblot
mainten
transfect
harvest
immunoblot
hela
cell
describ
previous
durfe
et
al
cell
provid
john
schiller
nci
bethesda
md
maintain
describ
buck
et
al
conjug
induc
treat
hela
cell
unitsml
ifnb
betaseron
either
hr
experi
shown
figur
lipofectamin
use
initi
transfect
xtremegen
sirna
transfect
reagent
roch
use
cotransfect
dna
sirna
slabel
puromycin
label
experi
cell
mm
dish
transfect
indic
plasmid
describ
label
hr
mci
scystein
cimmol
construct
use
experi
contain
mutat
elimin
cystein
residu
mutant
fulli
function
conjug
use
mutant
ensur
scysteinecontain
protein
detect
immunoprecipit
repres
label
cellular
protein
conjug
unlabel
oppos
unlabel
protein
conjug
slabel
similarli
construct
lack
cell
wash
pb
either
harvest
immedi
late
label
period
replenish
fresh
media
cell
lysat
collect
immunoprecipit
perform
antiflag
agaros
bead
sigma
immunoprecipit
separ
sdspage
label
protein
detect
autoradiographi
puromycin
experi
cell
transfect
indic
plasmid
treat
hr
posttransfect
puromycin
mm
final
concentr
min
total
cell
extract
prepar
conjug
precipit
antiflag
agaros
bead
sigma
immunoprecipit
analyz
immunoblot
antibodi
recogn
puromycin
hela
cell
harvest
hr
transfect
ifnb
stimul
describ
huang
et
al
except
heparin
mgml
ad
polysom
lysi
buffer
rnasin
omit
lysat
centrifug
min
g
c
supernat
load
onto
linear
wv
sucros
gradient
contain
cycloheximid
mgml
edta
treatment
cell
lyse
polysom
lysi
buffer
contain
mm
edta
mgcl
heparin
omit
appli
sucros
gradient
supplement
mm
edta
instead
mgcl
rnase
treatment
rnase
sigma
ad
lysat
heparin
omit
final
concentr
mgml
incub
c
min
appli
sucros
gradient
gradient
centrifug
g
min
c
beckmann
rotor
polysom
profil
monitor
absorb
nm
gradient
fraction
collect
isco
densiti
gradient
fraction
trichloroacet
acid
tca
ad
sucros
gradient
fraction
final
concentr
vv
protein
precipit
precipit
protein
prepar
sdspage
immunoblot
analys
cell
cotransfect
express
vector
either
four
isgyl
plasmid
set
four
plasmid
express
plu
inact
mutant
form
enzym
hr
cell
collect
pseudoviru
purifi
accord
previous
describ
protocol
buck
et
al
buck
thompson
ultracentrifug
use
optiprep
sigma
gradient
fraction
collect
peak
content
determin
via
sdspage
immunoblot
rel
amount
isgyl
nonisgyl
determin
use
fluoresc
secondari
antibodi
odyssey
system
licor
protein
concentr
determin
quantit
bsa
standard
colloid
coomassiestain
sdspage
gel
use
odyssey
system
well
infect
assay
cell
grown
plate
infect
equal
amount
psvcontain
fraction
sixti
hour
postinfect
cell
trypsin
subject
fac
analysi
use
facscalibur
machin
becton
dickinson
cellquest
pro
becton
dickinson
use
data
acquisit
analysi
live
cell
event
supplement
inform
includ
six
figur
three
tabl
found
articl
onlin
